D83 | °øÅë°¡º¯¼º ¸é¿ª°áÇÌÁõ | Common variable immunodeficiency |
|
D830 | B¼¼Æ÷ ¼ö ¹× ±â´ÉÀÇ ÇöÀúÇÑ ÀÌ»ó¿¡ ÀÇÇÑ °øÅë °¡º¯¼º ¸é¿ª°áÇÌ | Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function |
|
D831 | ÇöÀúÇÑ ¸é¿ªÁ¶ÀýT¼¼Æ÷ Àå¾Ö¿¡ ÀÇÇÑ °øÅë°¡º¯¼º ¸é¿ª°áÇÌ | Common variable immunodeficiency with predominant immunoregulatory T-cell disorders |
|
D832 | B ¶Ç´Â T¼¼Æ÷¿¡ ´ëÇÑ ÀÚ°¡Ç×ü¸¦ µ¿¹ÝÇÑ °øÅë °¡º¯¼º ¸é¿ª°áÇÌ | Common variable immunodeficiency with autoantibodies to B-or T-cells |
|
D838 | ±âŸ °øÅë°¡º¯¼º ¸é¿ª°áÇÌ | Other common variable immunodeficiencies |
|
D839 | »ó¼¼ºÒ¸íÀÇ °øÅë°¡º¯¼º ¸é¿ª°áÇÌ | Common variable immunodeficiency, unspecified |
|
D84 | ±âŸ ¸é¿ª°áÇÌ | Other immunodeficiencies |
|
D840 | ¸²ÇÁ±¸±â´ÉÇ׿ø-1°á¼Õ | Lymphocyte function antigen-1 [LFA-1] defect |
|
D841 | º¸Ã¼°èÅëÀÇ°á¼Õ | Defects in the complement system |
|
D841 | C1¿¡½ºÅÍ·¹À̽º ¾ïÁ¦ÀÎÀÚ°áÇÌ | C1 esterase inhibitor[C1-INH] dificiency |
|
D848 | ±âŸ ¸í½ÃµÈ ¸é¿ª°áÇÌ | Other specified immunodeficiencies |
|
D849 | »ó¼¼ºÒ¸íÀÇ ¸é¿ª°áÇÌ | Immunodeficiency, unspecified |
|
D86 | »ç¸£ÄÚÀ̵åÁõ | Sarcoidosis |
|
D860 | ÆóÀÇ »ç¸£ÄÚÀ̵åÁõ | Sarcoidosis of lung |
|
D861 | ¸²ÇÁÀýÀÇ »ç¸£ÄÚÀ̵åÁõ | Sarcoidosis of lymph nodes |
|
D862 | ¸²ÇÁÀýÀÇ »ç¸£ÄÚÀ̵åÁõÀ» µ¿¹ÝÇÑ ÆóÀÇ »ç¸£ÄÚÀ̵åÁõ | Sarcoidosis of lung with sarcoidosis of lymph nodes |
|
D863 | ÇǺÎÀÇ »ç¸£ÄÚÀ̵åÁõ | Sarcoidosis of skin |
|
D868 | ±âŸ ¹× º¹ÇÕ ºÎÀ§ÀÇ »ç¸£ÄÚÀ̵åÁõ | Sarcoidosis of other and combined sites |
|
D868 | »ç¸£ÄÚÀ̵åÁõ¿¡¼ÀÇ È«Ã¤¼¶¸ðü¿° | Iridocyclitis in sarcoidosis (H22.1*) |
|
D868 | »ç¸£ÄÚÀ̵åÁõ¿¡¼ÀÇ ´Ù¹ß¼º ³ú½Å°æ¸¶ºñ | Multiple cranial nerve palsies in sarcoidosis(G53.2*) |
|